Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
cancer
life sciences
national blog main
new york blog main
3
×
new york top stories
software
3
×
biotech
clinical trials
deals
detroit blog main
detroit top stories
fda
investing
national top stories
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
takeda pharmaceutical
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
a2 biotherapeutics
accelerator
aduro biotech
agency
agios pharmaceuticals
airbnb
akili interactive labs
alicia hager
alpha-1 antitrypsin
What
growing
admits
ago
alliance
big
bio
biotechs
bristol
buy
calls
changing
classes
color
combinator
companies
company’s
course
crispr
days
development
discover
dug
experimental
handiwork
helped
hours
incubator
internal
ipo
kudos
landscape
leaves
life
medicines
myers’s
notifying
october
phone
pipeline
previously
Language
unset
3
×
Current search:
software
×
unset
×
" new york blog main "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In